REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 40 filers reported holding REGULUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $50,000 | +35.1% | 168,172 | +42.9% | 0.00% | – |
Q4 2021 | $37,000 | -54.3% | 117,654 | 0.0% | 0.00% | – |
Q3 2021 | $81,000 | -15.6% | 117,654 | 0.0% | 0.00% | – |
Q2 2021 | $96,000 | -47.8% | 117,654 | 0.0% | 0.00% | – |
Q1 2021 | $184,000 | +247.2% | 117,654 | +198.4% | 0.00% | – |
Q4 2020 | $53,000 | +140.9% | 39,431 | -7.7% | 0.00% | – |
Q3 2020 | $22,000 | +37.5% | 42,702 | +77.8% | 0.00% | – |
Q2 2020 | $16,000 | +128.6% | 24,023 | +53.8% | 0.00% | – |
Q1 2020 | $7,000 | -50.0% | 15,621 | 0.0% | 0.00% | – |
Q4 2019 | $14,000 | +27.3% | 15,621 | 0.0% | 0.00% | – |
Q3 2019 | $11,000 | -42.1% | 15,621 | 0.0% | 0.00% | – |
Q2 2019 | $19,000 | +18.8% | 15,621 | 0.0% | 0.00% | – |
Q1 2019 | $16,000 | +14.3% | 15,621 | 0.0% | 0.00% | – |
Q4 2018 | $14,000 | – | 15,621 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 1,985,472 | $3,097,000 | 1.60% |
Endurant Capital Management LP | 2,376,557 | $3,707,000 | 0.97% |
Sarissa Capital Management LP | 1,851,851 | $2,888,000 | 0.28% |
NEA Management Company, LLC | 6,451,056 | $10,064,000 | 0.23% |
Atom Investors LP | 337,228 | $526,000 | 0.09% |
Ikarian Capital, LLC | 1,245,989 | $1,943,000 | 0.06% |
GYL FINANCIAL SYNERGIES, LLC | 51,376 | $80,000 | 0.04% |
Focused Wealth Management, Inc | 100,000 | $156,000 | 0.03% |
Point72 Asset Management, L.P. | 3,215,436 | $5,016,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 141,629 | $221,000 | 0.01% |